BADUNG, DEWATA.NEWS – Hundreds of doctors, researchers, and healthcare practitioners from Indonesia and abroad gathered in Bali for an international scientific conference focused on stem cell and regenerative medicine.
The Annual Scientific Meeting (PIT) 2026, organized by the Indonesian Society for Tissue Engineering and Cell Therapy (REJASELINDO), took place from April 2–4, 2026 at the Bali Nusa Dua Convention Center (BNDCC).
The three-day event serves as a platform for experts to exchange knowledge, present research findings, and strengthen international collaboration in the development of regenerative therapies.
Chair of the organizing committee, Prof. Dr. Ahmad Faried, emphasized the importance of the forum in advancing both research and clinical practice.
“Through this scientific forum, doctors and researchers can exchange clinical experiences and the latest developments in stem cell and cell therapy. We hope this collaboration will strengthen scientific evidence and drive innovation for diseases that are currently difficult to treat,” he said.
This year’s meeting was held in conjunction with several international and national forums, including the 20th International Conference of the Asia Pacific Association of Surgical Tissue Banking (APASTB), the 9th Annual Meeting of PERBAJI, and the 13th Annual Meeting of ASPI.
The collaboration brought together experts from multiple countries, reinforcing cross-border cooperation in tissue engineering and regenerative medicine.
Bali was selected as the host location due to its status as a major international conference destination in the Asia-Pacific region, providing a strategic meeting point for global participants.
The conference featured a comprehensive program, including workshops, main symposium sessions, and scientific competitions such as oral and poster presentations.
Participants included medical professionals, academics, and researchers with a shared interest in advancing regenerative medicine technologies.
Chairman of REJASELINDO, Dr. dr. Bintang Soetjahjo, highlighted the importance of cross-sector collaboration in developing cell-based therapies in Indonesia.
“We need a pentahelix collaboration involving academics, clinicians, government, industry, and media to accelerate innovation in regenerative medicine,” he said.
He added that Indonesia has strong potential not only to adopt but also to develop its own healthcare innovations.
“With strong collaboration, Indonesia can become a center for research-based healthcare technology and truly lead in its own country,” he stated.
Organizers expect the conference to accelerate research, innovation, and global collaboration in regenerative medicine, while opening new opportunities for future disease treatment.